Indianapolis—Oral rifaximin (Xifaxan, Salix) was found highly efficacious in simultaneously controlling abdominal pain and bloating in patients with irritable bowel syndrome and diarrhea, according to an analysis of a prospective study.
NOVEMBER 1, 2019